Fingerprint
Dive into the research topics of 'Vedolizumab versus Adalimumab for moderate-to-severe ulcerative colitis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Vedolizumab versus Adalimumab for moderate-to-severe ulcerative colitis
VARSITY Study Group
Research output: Contribution to journal › Article › peer-review
137
Scopus
citations